A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2010
At a glance
- Drugs Latrepirdine; Warfarin
- Indications Alzheimer's disease; Cardiovascular disorders; Huntington's disease
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 17 Mar 2010 Results presented at the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 20 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Jan 2009 New trial record.